呼吸器内科

論文業績 2019 年 10 月～2020 年 9 月

原著
1. Ryo Morita, Kyoichi Okishio, Junichi Shimizu, Haruhiro Saito, Hiroshi Sakai, Young Hak Kim,Osamu Hataji, Makiko Yomota, Makoto Nishio, Keisuke Aoe, Osamu Kanai, Toru Kumagai, Kayoko
Kibata, Hiroaki Tsukamoto, Satoshi Oizumi, Daichi Fujimoto, Hiroshi Tanaka, Keiko Mizuno,Takeshi Masuda, Toshiyuki Kozuki, Takashi Haku, Hiroyuki Suzuki, Isamu Okamoto, Hirotoshi
Hoshiyama, Junya Ueda, Yuichiro Ohe. Real-world effectiveness and safety of nivolumab in patientswith non-small cell lung cancer: A multicenter retrospective observational study in Japan.

Lung Cancer. 2020 Feb; 140:8-18.
2. Wakuda K, Yamaguchi H, Kenmotsu H, Fukuda M, Takeshita M, Suetsugu T, Kirita K, Ebi N,Hataji O, Miura S, Chibana K, Okamoto I, Yoshimura K, Nakagawa K, Yamamoto N, Sugio K.
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small
cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG9116L). BMC Cancer. 2020 May; 20(1):370.
3.William Mueller, Hilary Cowie, Claire J Horwell, Peter J Baxter, Damien McElvenny, Mark Booth,John W Cherrie, Paul Cullinan, Deborah Jarvis, Ciro Ugarte, Hiromasa Inoue. Standardized
epidemiological protocols for populations affected by volcanic eruptions. Bull World Health Organ.
2020 May 1;98(5):362-364.
4.Kay Wang, Jan Y Verbakel, Jason Oke, Alexander Fleming-Nouri, Josh Brewin, Nia Roberts,
Norihiro Harada, Ryo Atsuta, Kazuhisa Takahashi, Kazutaka Mori, Tomoyuki Fujisawa, ToshihiroShirai, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler, Fernando
Martinez, Dominick Shaw, Ian D Pavord, Mike Thomas. Using fractional exhaled nitric oxide toguide step-down treatment decisions in patients with asthma: a systematic review and individual
patient data meta-analysis. Eur Respir J. 2020 May 21; 55(5):1902150.
5.Kyoichi Okishio, Ryo Morita, Junichi Shimizu, Haruhiro Saito, Hiroshi Sakai, Young Hak Kim,Osamu Hataji, Makiko Yomota, Makoto Nishio, Keisuke Aoe, Osamu Kanai, Toru Kumagai, Kayoko
Kibata, Hiroaki Tsukamoto, Satoshi Oizumi, Daichi Fujimoto, Hiroshi Tanaka, Keiko Mizuno,Takeshi Masuda, Toshiyuki Kozuki, Takashi Haku, Hiroyuki Suzuki, Isamu Okamoto, Hirotoshi
Hoshiyama, Nobumichi Yada, Yuichiro Ohe. Nivolumab treatment of elderly Japanese patients withnon-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA2099CR). ESMO Open. 2020 Jul; 5(4): e000656.
6. Kay Wang, Jan Y Verbakel, Jason Oke, Alexander Fleming-Nouri, Norihiro Harada, Ryo Atsuta,

Tomoyuki Fujisawa, Tomotaka Kawayama, Hiromasa Inoue, Stephen Lazarus, Stanley Szefler,Fernando D Martinez, Dominick Shaw, Ian D Pavord, Mike Thomas. Using fractional exhaled nitricoxide to guide step-down treatment decisions in asthma: practical considerations. Eur Respir J.
2020 Aug 20; 56(2): 2002809.

7.Mizuno K, Kengo Tanigawa, Nijiro Nohata, Shunsuke Misono, Reona Okada, Shunichi Asai,
Shogo Moriya, Takayuki Suetsugu, Hiromasa Inoue, Naohiko Seki. FAM64A: A Novel Oncogenic
Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a3p). Cells. 2020 Sep 11; 9(9): E2083.
8.Christopher E Brightling, Mina Gaga, Hiromasa Inoue, Jing Li, Jorge Maspero, Sally Wenzel,Samopriyo Maitra, David Lawrence, Florian Brockhaus, Thomas Lehmann, Caterina Brindicci,
Barbara Knorr, Eugene R Bleecker. Effectiveness of fevipiprant in reducing exacerbations inpatients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials.

Lancet Respir Med. 2020 Sep 24; S2213-2600(20): 30412-30414.

総説
1. 町田健太朗，井上博雅：アレルギーと感染症.(特集/アレルギー疾患の最新の治療）臨牀と研究.
2020.3; 97(3): 73(341)-76(344).
2. 東元一晃，眞田宏樹，宮田真里奈，冨岡勇也，八木朋子，中塩屋二郎：新型コロナウイルス感染症
COVID-19～第 2 波に備える鹿児島の現状と展望～鹿児島市医報. 2020.6.20; 59(7): 29-34.

3. 籾博晃：慢性閉塞性肺疾患（COPD)(特集：投薬御フォローまで、これで完璧！吸入療法コンプリー
ト/3 吸入療法の位置づけ）

調剤と情報. 2020.9; 26(12): 20(2090)-24(2094).

4. 堂嶽洋一，東元一晃：喘息治療を成功させるためのデバイス選択と吸入指導.（特集：喘息のオーダーメイド診療） 呼吸器内科. 2020.9.28; 38(3):220-226.

著書
町田健太朗,井上博雅：増悪の診断と重症度判定.(6 章

増悪期の管理と増悪予防）

COPD 慢性閉塞性肺疾患（呼吸器疾患 診断治療アプローチ）. 306－310.
新呼吸器専門医テキスト 改訂第 2 版．2020.8.5;(日本呼吸器学会教育委員会委員長 井上博雅）

1．水野圭子： 7．嗄声（音声障害） （総論Ⅲ 主要症候と身体所見）50-52.
2．町田健太朗：2．慢性閉塞性肺疾患（COPD）－治療と予後－（各論Ⅰ 起動・肺疾患）364-369.

症例
1. Furukawa Y, Hamada H, Kamikawaji K, Unoki T, Inoue H, Tashiro Y, Okamoto M, Baba M,Hashiguchi T.

Successful treatment of an AIDS patient with prolonged Mycobacterium avium

bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis. J InfectChemother. 2020 Feb; 26(2): 279-281.

その他
1. (随想)井上博雅：雑誌『呼吸』の想い出とこれから. 呼吸 e レポート．2019.11.20; 3(2): 156-158.